Retro Biosciences
Longevity · United States · Founded 2021 · private
Retro Biosciences dosed the first humans with RTR242, an oral drug meant to restart autophagy, in December 2025: a Phase 1 safety study in Australia, and the only ageing-biology programme from the Altman-funded cohort to reach the clinic.
The record
1 figures · 2 rounds · 2 backers · 4 feed items
Every one of them carries its source, its date, and its age when it has one. Reading the record takes a free account; the account is how you keep a watchlist.